- Janssen Pharmaceutica N.V., Belgium
- MAL19992548AZ
- Risperidone 1 mg/mL
Schizophrenia: Treatment of acute and chronic psychotic disorders
Bipolar Disorder: Management of moderate to severe manic episodes
Alzheimer’s Dementia: Short-term treatment (up to 6 weeks) of persistent aggression unresponsive to non-pharmacological approaches
Conduct Disorder: Short-term symptomatic treatment (up to 6 weeks) of persistent aggression in children aged 5 years and older with subaverage intellectual functioning or mental retardation
Dosage:
Adults: Typically, 2 mg/day, adjusted based on individual response
Children (≥5 years): Starting dose of 0.5 mg/day, adjusted as necessary
Administration: Take orally, with or without food
Storage: Store below 30°C, away from light and moisture
Precautions: Monitor for side effects such as sedation, weight gain, and extrapyramidal symptoms; adjust dosage as needed